Biotechnology Company Renovis
Completes New Venture Round

By

David P. Hamilton Staff Reporter of The Wall Street Journal

Updated Jan. 9, 2002 10:13 a.m. ET

SOUTH SAN FRANCISCO -- Renovis Inc., a biotechnology firm specializing in neurological disorders, has completed a $34.3 million round of venture financing. It is the second venture round for the closely held firm (www.renovis.com).

The funding was led by HBM BioVentures AG, an investment firm specializing in biotechnology led by former Roche Holding AG finance head Henri Meier. New investors include Applied Genomic Technology Capital...